Journals / The European Research Journal / 2019 / Cilt: 5 - Sayı: 6

Diagnostic utility of clinical and epidemiologic features in fever of unknown origin

Pages
928–938
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusions: We identified clinical data emerging from the anamnesis and physical examination that may help to guide the diagnostic process in FUO.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: To assess the diagnostic utility of clinical features in the major diagnostic categories of Fever of unknown origin (FUO).
📊
Key Findings & Data:Sensitivity, specificity, positive and negative predictive values (PPV and NPVs), and likelihood ratios of positive and negative tests (LR+ and LR-) were estimated with 95% confidence intervals (95% CIs) for all clinical findings.
💡
Conclusion & Impact:Conclusions: We identified clinical data emerging from the anamnesis and physical examination that may help to guide the diagnostic process in FUO.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Fever of unknown origin · clinical features · diagnostic utility

Abstract

Objectives: To assess the diagnostic utility of clinical features in the major diagnostic categories of Fever of unknown origin (FUO). Methods: One hundred and thirty-three patients meeting the classic criteria of FUO were included in the study. A structured diagnostic protocol was used in all cases. Sensitivity, specificity, positive and negative predictive values (PPV and NPVs), and likelihood ratios of positive and negative tests (LR+ and LR-) were estimated with 95% confidence intervals (95% CIs) for all clinical findings. Results: Clinical and epidemiologic features with best diagnostic utility indexes for the three major diagnostic categories were: weight loss of 15 pounds or more (sensitivity, 68.4%, 95% CI: 52.33-84.52), pallor of the skin and mucous membranes (sensitivity, 65.7%, 95% CI: 49.39-82.19), prior medical history of cancer (PPV, 63.6%, 95% CI: 30.66-96.61; LR+, 4.38, 95% CI: 1.36-14.09), lymphadenopathy (LR+, 2.2, 95% CI: 1.11-4.74), for neoplasms; arthritis (PPV, 72%, 95% CI: 51.84-93.61), prior family history of collagen diseases (PPV, 100%, 95% CI: 91.67-100.00), neurologic disorder (LR+, 5.1, 95% CI: 1.37-19.68), myalgia (LR+, 4.1, 95% CI: 1.45-11.88) and skin lesions (LR+, 3.0, 95% CI: 1.51-6.22) for noninfectious inflammatory diseases; weight loss of 15 pounds or more (sensitivity, 50%, 95% CI: 27.91-72.09), epidemiological history of previous tuberculosis or tuberculosis exposure (LR+, 9.0, 95% CI: 1.76-46.77), and jaundice (LR+, 2.73, 95% CI: 0.7-10.63) for infections. Conclusions: We identified clinical data emerging from the anamnesis and physical examination that may help to guide the diagnostic process in FUO.

🔖

Cite This Article

CAMPA, V. R., PANEQUE, R. E. J. N., SİLVA, H. C. M. R. G. (2019). Diagnostic utility of clinical and epidemiologic features in fever of unknown origin. The European Research Journal, Cilt: 5 - Sayı: 6, 928–938. https://ajindex.com/articles/361123

References (14)

  1. Petersdorf RG, Beeson PB. Fever of unexplained origin: report on 100 cases. Medicine (Baltimore) 1961;40:1-30
  2. Tolia J, Smith LG. Fever of unknown origin: historical and physical clues to making the diagnosis. Infect Dis Clin North Am 2007;21:917-36
  3. Cunha BA. Fever of unknown origin: focused diagnostic approach based on clinical clues from the history, physical examination, and laboratory tests. Infect Dis Clin North Am 2007;21:1137-87
  4. Mulders-Manders CM, Simon A, Bleeker-Rovers CP. Rheumatologic diseases as the cause of fever of unknown origin. Best Pract Res Clin Rheumatol 2016;30:789-801
  5. Larson EB, Featherstone HJ, Petersdorf RG. Fever of undetermined origin: diagnosis and follow-up of 105 cases, 1970-1980. Medicine (Baltimore) 1982;61:269-92. [6] de Kleijn EM, van Lier HJ, van der Meer JW. Fever of unknown origin (FUO). II. Diagnostic procedures in a prospective multicenter study of 167 patients. The Netherlands FUO Study Group. Medicine (Baltimore) 1997;76:401-14
  6. Gaeta GB, Fusco FM, Nardiello S. Fever of unknown origin: a systematic review of the literature for 1995-2004. Nucl Med Commun 2006;27:205-11
  7. Vanderschueren S, Knockaert D. Tackling fever and inflammation of unknown origin: the do's and don'ts. Acta Clin Belg 2014;69:412-17
  8. Mourad O, Palda V, Detsky AS. A comprehensive evidence-based approach to fever of unknown origin. Arch Intern Med 2003;163:545-51
  9. Cunha BA. Fever of unknown origin: clinical overview of classic and current concepts. Infect Dis Clin North Am 2007;21:867-915
  10. Takeda R, Mizooka M, Kobayashi T, Kishikawa N, Yokobayashi K, Kanno K, et al. Key diagnostic features of fever of unknown origin: medical history and physical findings. J Gen Fam Med 2017;18:131-34
  11. Cunha BA, Lortholary O, Cunha CB. Fever of unknown origin: a clinical approach. Am J Med 2015;128:1138.e1-1138.e15
  12. De Kleijn EMHA, Vandenbroucke JP, Van Der Meer JWM, and The Netherlands FUO Study Group. Fever of unknown origin (FUO). I. A prospective multicenter study of 167 patients with FUO, using fixed epidemiologic entry criteria. Medicine (Baltimore) 1997;76:392-400
  13. Bleeker-Rovers CP, Vos FJ, de Kleijn EM, Mudde AH, Dofferhoff TS, Richter C, et al. A prospective multicenter study on fever of unknown origin. the yield of a structured diagnostic protocol. Medicine (Baltimore) 2007;86:26-38
  14. Iikuni Y, Okada J, Kondo H, Kashiwazaki S. Current fever of unknown origin 1982-1992. Intern Med 1994;33:67-73.